These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34934777)

  • 1. Inflammatory Bowel Disease Patients' Perspectives during COVID-19 Pandemic: Results from a Portuguese Survey.
    Revés JB; Frias-Gomes C; Morão B; Nascimento C; Palmela C; Fidalgo C; Roque Ramos L; Sampaio A; Glória L; Cravo M; Torres J
    GE Port J Gastroenterol; 2021 Sep; 5(5):1-9. PubMed ID: 34934777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with inflammatory bowel disease on immunosuppressive drugs: perspectives' on COVID-19 and health care service during the pandemic.
    Moum KM; Moum B; Opheim R
    Scand J Gastroenterol; 2021 May; 56(5):545-551. PubMed ID: 33771086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability and quality of life before and during the COVID-19 outbreak: A cross-sectional study in inflammatory bowel disease patients.
    Azzam NA; Aljebreen A; Almuhareb A; Almadi MA
    Saudi J Gastroenterol; 2020; 26(5):256-262. PubMed ID: 32415045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path toward the implementation of telemedicine in Spain?
    Del Hoyo J; Millán M; Garrido-Marín A; Nos P; Barreiro-de Acosta M; Bujanda L; de la Portilla F; Aguas M;
    Gastroenterol Hepatol; 2022 Nov; 45(9):697-705. PubMed ID: 34508808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the future.
    Viganò C; Mulinacci G; Palermo A; Barisani D; Pirola L; Fichera M; Invernizzi P; Massironi S
    World J Gastroenterol; 2021 Sep; 27(33):5520-5535. PubMed ID: 34588749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?
    Schlabitz F; Teich N; Riesner-Wehner A; Böhm S; Greinert R; Eisenmann S; Michl P; Walldorf J
    J Clin Gastroenterol; 2022 Feb; 56(2):e126-e130. PubMed ID: 33538442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic.
    Ling KL; Hilmi I; Raja Ali RA; Leong RWL; Leung WK; Ng SC; Wu KC; Chen MH; Ran ZH; Hisamatsu T; Ahuja V; Makharia GK; Banerjee R; Wei SC; Wu DC; Pisespongsa P; Ye BD; Sollano J; Simadibrata M; Chuah SW; Ooi CJ
    JGH Open; 2020 Jun; 4(3):320-323. PubMed ID: 32514431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding telehealth options during the COVID pandemic eliminated racial and age disparities in electronic communication by inflammatory bowel disease patients.
    Hayrapetian L; Zepp M; Rao S; Hennessey M; Houle M; Atienza M; Belfaqeeh OA; Dharia I; Khan A; Borum ML
    J Natl Med Assoc; 2021 Aug; 113(4):474-477. PubMed ID: 33941370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perception of the COVID-19 Pandemic Among Patients With Inflammatory Bowel Disease in the Time of Telemedicine: Cross-Sectional Questionnaire Study.
    Zingone F; Siniscalchi M; Savarino EV; Barberio B; Cingolani L; D'Incà R; De Filippo FR; Camera S; Ciacci C
    J Med Internet Res; 2020 Nov; 22(11):e19574. PubMed ID: 33006945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
    Nakase H; Wagatsuma K; Nojima M; Matsumoto T; Matsuura M; Iijima H; Matsuoka K; Ohmiya N; Ishihara S; Hirai F; Takeuchi K; Tamura S; Kinjo F; Ueno N; Naganuma M; Watanabe K; Moroi R; Nishimata N; Motoya S; Kurahara K; Takahashi S; Maemoto A; Sakuraba H; Saruta M; Tominaga K; Hisabe T; Tanaka H; Terai S; Hiraoka S; Takedomi H; Narimatsu K; Endo K; Nakamura M; Hisamatsu T
    J Gastroenterol; 2023 Mar; 58(3):205-216. PubMed ID: 36607399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of inflammatory bowel disease and related medications on COVID-19 incidence, disease severity, and outcome: the Israeli experience.
    Richter V; Bermont A; Cohen DL; Broide E; Shirin H
    Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):267-273. PubMed ID: 34191758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Views of patients with inflammatory bowel disease during the COVID-19 pandemic: ACCU survey results.
    Fernández Álvarez P; Belvis Jiménez M; Maldonado Pérez B; Castro Laria L; Caunedo Álvarez Á; Rodríguez de Los Ríos JL; Argüelles-Arias F
    Rev Esp Enferm Dig; 2021 Feb; 113(2):92-97. PubMed ID: 33371692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding attitudes, concerns, and health behaviors of patients with inflammatory bowel disease during the coronavirus disease 2019 pandemic.
    Goodsall TM; Han S; Bryant RV
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1550-1555. PubMed ID: 33063927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Pandemic's Effects on Disease and Psychological Outcomes of People With Inflammatory Bowel Disease in Portugal: A Preliminary Research.
    Trindade IA; Ferreira NB
    Inflamm Bowel Dis; 2021 Jul; 27(8):1224-1229. PubMed ID: 33043977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A more frequent disease monitorering but no increased disease activity in patients with inflammatory bowel disease during the first year of the SARS-CoV-2 pandemic. A retrospective study.
    Lindhagen S; Karling P
    Scand J Gastroenterol; 2022 Feb; 57(2):169-174. PubMed ID: 34699290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery from COVID-19 Pneumonia in a Patient with Acute Severe Colitis.
    Garcia KS; Moutinho BD; de Azevedo MFC; Queiroz NSF; Milani LR; Sanches LN; Barros LL; Oba J; Carlos AS; Damião AOMC; Sipahi AM
    Inflamm Intest Dis; 2020 Jun; 5(2):93-97. PubMed ID: 32984404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Children and Expectant Mothers With Inflammatory Bowel Disease.
    Benchimol EI; Carroll MW; Geist R; Griffiths AM; Huang JG; Mack DR; Bernstein CN; Bitton A; Jones JL; Kaplan GG; Kuenzig ME; Lee K; Mukhtar MS; Murthy SK; Tandon P; Targownik LE; Windsor JW; Seow CH
    J Can Assoc Gastroenterol; 2021 Dec; 4(Suppl 2):S27-S33. PubMed ID: 34755036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IBD Patients' Perception of Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic and Satisfaction with Provided Healthcare: A Cross-Sectional Study.
    Hrabar D; Cacic P; Biscanin A; Tomasic V; Kralj D; Ogresta D; Pelajic S; Dorosulic Z; Babarovic T
    Turk J Gastroenterol; 2022 Mar; 33(3):190-195. PubMed ID: 35115285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic.
    Vadan R; Iacob R; Costache R; Stroie T; Saizu IA; Iacob S; Gheorghe L; Diculescu M; Gheorghe C
    J Gastrointestin Liver Dis; 2020 Dec; 29(4):549-553. PubMed ID: 33331349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.